They were first developed to treat type 2 diabetes, but millions of people now use them for weight loss, too
The medication can take up to 80 days to metabolize completely out of the body
Safety and efficacy of combination treatment with calcineurin inhibitors and vedolizumab in patients with refractory inflammatory bowel disease
Researchers at Colorado State University and Sam Houston State University are recruiting participants for a study (Experiences of GLP-1 Medications for Weight Loss and Transformations in Body, Identity, and Dress, CSU IRB #7666)
Many reported DNMT, HAT, and HDAC inhibitory effects of curcumin are concentration-dependent and not always reproducible across experimental systems
Imaging studies, such as X-rays or CT scans are crucial to pinpoint the fractures location and severity